NASDAQ:XLO | EBITDA | Xilio Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$13.77M
2025-12-31-$11.51M
2025-03-31-$13.35M
2024-12-31-$13.25M
2024-03-31-$17.04M
2023-12-31-$17.68M
2023-03-31-$23.03M
2022-12-31-$22.68M
2022-03-31-$20.78M
2021-12-31-$19.16M
2021-03-31-$16.17M
2020-12-31-$20.25M

Annual EBITDA

DateEBITDA
2025-12-31-$40.44M
2024-12-31-$58.94M
2023-12-31-$77.23M
2022-12-31-$87.3M
2021-12-31-$73.55M
2020-12-31-$53.5M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.